Published in Cancer Weekly, September 25th, 2001
According to doctors, pseudomembranous colitis is a more frequent side effect in patients who take cancer therapies than ischemic colitis, but in Naples, Italy, investigators at the National Cancer Institute reported that a patient on combination paclitaxel/carboplatin therapy was diagnosed with the rarer type of colitis.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.